Welcome to our dedicated page for brks news (Ticker: brks), a resource for investors and traders seeking the latest updates and insights on brks stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect brks's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of brks's position in the market.
Brooks Automation (Nasdaq: BRKS) has announced the rebranding of its Life Sciences Services and Products as Azenta Life Sciences. This new identity aims to provide integrated solutions for sample exploration and management. Azenta will focus on automated ultra-cold sample storage, genomic services, data management, and consumables. The company emphasizes its commitment to helping customers accelerate scientific progress. Azenta's operations span North America, Europe, and Asia, consolidating legacy brands under its name to enhance service capabilities.
Thomas H. Lee Partners announced an agreement to acquire Brooks Automation's Semiconductor Solutions Group for $3 billion. The transaction is set to close in the first half of 2022, pending regulatory approvals. This move aligns with Brooks' strategy to split into two independent firms, enhancing its focus on automation technology. Brooks reported $613 million in revenue in the last twelve months leading up to June 30, 2021. The semiconductor market is poised for growth, with projections reaching $1 trillion by 2030.
Brooks Automation (Nasdaq: BRKS) announced its participation in two virtual investor conferences: the 6th Annual Needham Virtual Med Tech & Diagnostics 1x1 Conference on August 17, 2021, and the Needham 2nd Annual SemiCap and EDA 1x1 Conference on August 24, 2021. This follows Brooks' plans to separate into two independent companies focused on Life Sciences and Semiconductor Solutions by the end of 2021. Brooks operates globally in North America, Europe, and Asia, providing advanced solutions for pharmaceutical and semiconductor industries.
Brooks Automation (BRKS) reported a strong fiscal Q3 2021, with revenue of $315 million, a 43% increase year-over-year. Both segments, Life Sciences and Semiconductor Solutions, saw significant growth, up 38% and 47%, respectively. Diluted EPS from continuing operations rose to $0.53, a 184% increase from the prior year. Management anticipates continued growth into Q4 2021, projecting revenue between $328 million to $348 million and non-GAAP EPS of $0.71 to $0.81. The company's cash position is strong, with $286 million in liquid assets and total debt of $50 million.
Brooks Automation (Nasdaq: BRKS) will announce its fiscal 2021 Q3 earnings on August 5, 2021, following the market close. The conference call will occur at 4:30 p.m. ET on the same day, accessible via phone or a live webcast. Brooks operates in two sectors: Life Sciences, which offers cold-chain management and genomic services, and Semiconductor Solutions, providing automation systems and robotics for the semiconductor industry. The company plans to separate into two independent entities by the end of 2021, enhancing focus on both segments.
Brooks Automation (Nasdaq: BRKS) will participate in the 13th Annual Virtual CEO Investor Summit on June 15, 2021. This invitation-only event allows accredited investors and analysts to engage in small group meetings with company management. Brooks operates in Life Sciences and Semiconductor Solutions, with plans to separate into two independent publicly traded companies by the end of 2021. The Life Sciences division includes genomic services, while Semiconductor Solutions focuses on automation systems for chip manufacturers.
Brooks Automation (Nasdaq: BRKS) announced participation in two virtual investor conferences. The first is the Evercore ISI Inaugural Technology, Media, and Telecom Conference on June 8, 2021, at 3:30 p.m. ET, followed by the Stifel 2021 Virtual Cross Sector Insight Conference on June 9, 2021, at 12:40 p.m. ET. Live webcasts are accessible via Brooks' investor relations website, with replays available after the events. Additionally, Brooks plans to separate into two independent companies by year-end 2021, focusing on Life Sciences and Semiconductor Solutions.
Brooks Automation (Nasdaq: BRKS) will participate in the Jefferies Virtual Healthcare Conference on June 4, 2021, with a live webcast at 9:00 a.m. ET. This event can be accessed through the Brooks investor relations website, and a replay will be available afterwards.
On May 10, 2021, Brooks announced plans to separate into two independent publicly traded companies, one focusing on Life Sciences and the other on Semiconductor Solutions, expected to complete by year-end 2021.
Brooks Automation (Nasdaq: BRKS) will participate in the 16th Annual Needham Virtual Technology & Media Conference on May 20, 2021, with a live webcast starting at 11:00 a.m. ET. Interested investors can access the webcast on the Brooks investor relations website. Brooks operates two main businesses: Life Sciences, which focuses on cold-chain sample management and genomic services, and Semiconductor Solutions, providing automation and robotics to semiconductor manufacturers. The company plans to separate into two independent publicly traded entities by the end of 2021.
Brooks Automation, Inc. (Nasdaq: BRKS) reported a 30% increase in revenue for Q2 FY2021, reaching $287 million, driven by growth in both Life Sciences (up 36%) and Semiconductor Solutions (up 26%). Diluted EPS for continuing operations was $0.32, a 158% increase year-over-year. The company plans to separate into two independent entities by year-end 2021. Adjusted EBITDA rose 105% to $71 million. Cash flow from operations was $34 million, with a total cash balance of $334 million against $50 million in debt. Guidance for Q3 expects revenue between $300 million and $320 million.
